Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy

References

1. Aguero-Rosenfeld M. E., Nowakowski J., Bittker S., Cooper D., Nadelman R. B., Wormser G. P. 1996; Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol 34:1–9
   [Google Scholar]
2. Bacon R. M., Biggerstaff B. J., Schriefer M., Gilmore R. D., Philipp M. T., Steere A., Wormser G. P., Marques A. R., Johnson B. J. B. 2003; Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with two-tiered testing using whole-cell lysates. J Infect Dis 187:1187–1199 [CrossRef]
   [Google Scholar]
3. Baranton G., Postic D., Saint Girons I., Boerlin P., Piffaretti J. C., Assous M., Grimont P. A. D. 1992; Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp.nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42:378–383 [CrossRef]
   [Google Scholar]
4. Centers for Disease Control & Prevention; 1995; Recommendations for test performance and interpretation from the Second National Conference on Serological Diagnosis of Lyme Disease. Morb Mortal Wkly Rep 44:590–591
   [Google Scholar]
5. Cevenini R., Sambri V., Massaria F., Franchini R., D'Antuono A., Borda G., Negosanti M. 1992; Surface immunofluorescence assay for diagnosis of Lyme disease. J Clin Microbiol 30:2456–2461
   [Google Scholar]
6. Ciceroni L., Ciarrochi S., Ciervo A., Mondarini V., Guzzo F., Caruso G., Murgia R., Cinco M. 2001; Isolation and characterization of Borrelia burgdorferi sensu lato strains in an area of Italy where Lyme borreliosis is endemic. J Clin Microbiol 39:2254–2260 [CrossRef]
   [Google Scholar]
7. Gern L., Estrada-Pena A., Frandsen F. & 7 other authors; 1998; European reservoir hosts of Borrelia burgdorferi sensu lato. Zentbl Bakteriol 287:196–204 [CrossRef]
   [Google Scholar]
8. Hauser U., Lehnert G., Lobentanzer R., Wilske B. 1997; Interpretation criteria for standardized Western blots for three European species of Borrelia burgdorferi sensu lato. J Clin Microbiol 35:1433–1444
   [Google Scholar]
9. Hauser U., Krahl H., Peters H., Fingerle V., Wilske B. 1998; Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato. J Clin Microbiol 36:427–436
   [Google Scholar]
10. Hauser U., Lehnert G., Wilske B. 1999; Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe. J Clin Microbiol 37:2241–2247
    [Google Scholar]
11. Heikkila T., Seppala I., Saxen H., Panelius J., Yrjanainen H., Lahdenne P. 2002; Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B.afzelii , and B. garinii by using decorin binding protein A. J Clin Microbiol 40:453–460 [CrossRef]
    [Google Scholar]
12. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685 [CrossRef]
    [Google Scholar]
13. Lawrenz M. B., Hardham J. M., Owens R. T., Nowakowski J., Steere A. C., Wormser G. P., Norris S. J. 1999; Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi . J Clin Microbiol 37:3997–4004
    [Google Scholar]
14. Liang F. T., Steere A. C., Marques A. R., Johnson B. J. B., Miller J. N., Philipp M. T. 1999; Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol 37:3990–3996
    [Google Scholar]
15. Magnarelli L. A., Miller J. N., Anderson J. F., Riviere G. F. 1990; Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease. J Clin Microbiol 28:1276–1279
    [Google Scholar]
16. Magnarelli L. A., Anderson J. F., Johnson R. C., Nadelman R. B., Wormser G. P. 1994; Comparison of different strains of Borrelia burgdorferi sensu lato used as antigens in enzyme-linked immunosorbent assays. J Clin Microbiol 32:1154–1158
    [Google Scholar]
17. Magnarelli L. A., Ijdo J. W., Padula S. J., Flavell R. A., Fikrig E. 2000; Serologic diagnosis of Lyme borreliosis by using enzyme-linked immunosorbent assays with recombinant antigens. J Clin Microbiol 38:1735–1739
    [Google Scholar]
18. Magnarelli L. A., Lawrenz M., Norris S. J., Fikrig E. 2002; Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. J Med Microbiol 51:649–655
    [Google Scholar]
19. Marangoni A., Sambri V., Cimmino C., Caruso G., Mondardini V., Cevenini R. 1999; Evaluation of the immune response in culture-confirmed Lyme borreliosis erythema migrans patients. Zentbl Bakteriol 289:736–739 [CrossRef]
    [Google Scholar]
20. Marconi R. T., Garon C. F. 1992; Development of chain reaction primers sets for diagnosis of Lyme disease and for species-specific identification of Lyme disease isolates by 16S rRNA signature nucleotide analysis. J Clin Microbiol 30:2830–2834
    [Google Scholar]
21. Nadelman R. B., Wormser G. P. 1998; Lyme borreliosis. Lancet 352:557–565 [CrossRef]
    [Google Scholar]
22. Nadelman R. B., Nowakowski J., Forseter G., Goldberg N. S., Bittker S., Cooper D., Aguero-Rosenfeld M., Wormser G. P. 1996; The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 100:502–508 [CrossRef]
    [Google Scholar]
23. O'Connell S., Granström M., Gray J. S., Stanek G. 1998; Epidemiology of European Lyme borreliosis. Zentbl Bakteriol 287:229–240 [CrossRef]
    [Google Scholar]
24. Peltomaa M., McHugh G., Steere A. C. 2003; Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J Infect Dis 187:1178–1186 [CrossRef]
    [Google Scholar]
25. Picken R. N. 1992; Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever. J Clin Microbiol 30:99–114
    [Google Scholar]
26. Robertson J., Guy E., Andrews N. & 9 other authors; 2000; A European multicenter study of immunoblotting in serodiagnosis of lyme borreliosis. J Clin Microbiol 38:2097–2102
    [Google Scholar]
27. Sambri V., Marangoni A., Olmo A., Storni E., Montagnani M., Fabbi M., Cevenini R. 1999; Specific antibodies reactive with the 22-kilodalton major outer surface protein of Borrelia anserina Ni-NL protect chicks from infection. Infect Immun 67:2633–2637
    [Google Scholar]
28. Sambri V., Marangoni A., Eyer C., Reichhuber C., Soutschek E., Negosanti M., D'Antuono A., Cevenini R. 2001; Western immunoblotting with five Treponema pallidum recombinant antigens for serological diagnosis of syphilis. Clin Diagn Lab Immunol 8:534–539
    [Google Scholar]
29. Sambri V., Marangoni A., Giacani L., Gennaro R., Murgia R., Cevenini R., Cinco M. 2002; Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira , Borrelia and Treponema pallidum . J Antimicrob Chemother 50:895–902 [CrossRef]
    [Google Scholar]
30. Stanek G., Strle F. 2003; Lyme borreliosis. Lancet 362:1639–1647 [CrossRef]
    [Google Scholar]
31. Steere A. C. 1994; Lyme disease: a growing threat to urban populations. Proc Natl Acad Sci U S A 91:2378–2383 [CrossRef]
    [Google Scholar]
32. Strle F., Nelson J. A., Ruzic-Sabljic E. & 7 other authors; 1996; European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans. Clin Infect Dis 23:61–65 [CrossRef]
    [Google Scholar]
33. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A 76:4350–4354 [CrossRef]
    [Google Scholar]
34. Wang G., van Dam A. P., Schwartz I., Dankert J. 1999; Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 12:633–653
    [Google Scholar]
35. Wilske B., Busch U., Eiffert H., Fingerle V., Pfister H. W., Rössler D., Preac-Mursic V. 1996; Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany. Med Microbiol Immunol 184:195–201 [CrossRef]
    [Google Scholar]
36. Wilske B., Zöller L., Brade V., Eiffert M., Göbel U. B., Stanek G., Pfister H. W. 2000; MIQ 12 Lyme-Borreliose. In Qualitätsstandards in der Mikrobiologisch-Infektiologischen Diagnostik pp 1–59 Edited by Mauch H., Lütticken R. Munich, Germany: Urban & Fischer Verlag;
    [Google Scholar]
37. Wormser G. P., Carbonaro C., Miller S., Nowakowski J., Nadelman R. B., Sivak S., Aguero-Rosenfeld M. E. 2000; A limitation of 2-stage serological testing for Lyme disease: enzyme immunoassay and immunoblot assay are not independent tests. Clin Infect Dis 30:545–548 [CrossRef]
    [Google Scholar]
38. Zhang J. R., Hardham J. M., Barbour A. G., Norris S. J. 1997; Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275–285 [CrossRef]
    [Google Scholar]